Sublingual cannabis extract spray: GWP started a European Phase III trial trials of its sublingual cannabis extract spray to treat multiple sclerosis a subset o

GW Pharmaceuticals plc (LSE:GWP), Salisbury, U.K. Product: Sublingual cannabis extract spray Business: Neurological Therapeutic category: Receptor agonist Target: Cannabinoid receptors Description: S...